SIRT2 and Parkinson disease: Notably, AGK2 treatment of a Drosophila model of Parkinson’s disease attenuated α-synuclein-mediated toxicity in dorsomedial neurons, implicating Sirt2 as a therapeutic target for inhibition in Parkinson’s disease [129].